Eagle pharmaceuticals revenue

WebMar 13, 2024 · The specialty pharmaceutical company posted revenue of $60.7 million in the period. For the year, the company reported net income of $35.6 million, or $2.73 per share, swinging to a profit in the period. Revenue was reported as $316.6 million. Eagle Pharmaceuticals expects full-year earnings in the range of $4.20 to $4.53 per share. … WebEagle Pharmaceuticals Financials Summary financials Revenue ( Q3, 2024) $65.9M Gross profit ( Q3, 2024) $45.0M Net income ( Q3, 2024) ($7.1M) Cash ( Q3, 2024) …

Eagle Pharmaceuticals (EGRX) Q3 Earnings and Revenues Beat …

WebMar 13, 2024 · Fourth Quarter 2024. Total revenue for Q4 2024 was $60.7 million, compared to $42.3 million in Q4 2024. Q4 2024 net income was $8.2 million, or $0.63 per basic and $0.62 per diluted share, compared to net loss of $ (6.2) million, or $ (0.48) per … WebApr 5, 2024 · Eagle Pharmaceuticals (NASDAQ:EGRX) has a market capitalization of $396.32 million and generates $316.61 million in revenue each year. The specialty … can chewable vetmedin be crushed https://ccfiresprinkler.net

Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2024 …

WebMar 13, 2024 · Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings and Revenue Estimates Zacks Mar. 13, 2024, 08:05 AM Eagle Pharmaceuticals (EGRX) came out with quarterly earnings of $1.10 per share,... WebMay 9, 2024 · Q1 2024 total revenue was $115.9 million, up from $41.2 million in Q1 2024. Achieved sales of $34.3 million of vasopressin, with prior four weeks average market … WebMar 13, 2024 · Full Year 2024. Total revenue for the 12 months ended December 31, 2024 was $316.6 million, compared to $171.5 million, in 2024, an increase of 84.6%. Net income for the 12 months ended December 31, 2024 was $35.6 million, or $2.76 per basic and $2.73 per diluted share, compared to net loss of $ (8.6) million, or $ (0.66) per basic and … fish in light bulb photoshop tutorial

Health Information Technology - Entry Level /Recent Grad

Category:Eagle Pharmaceuticals (EGRX) Price To Free Cash Flow - Zacks.com

Tags:Eagle pharmaceuticals revenue

Eagle pharmaceuticals revenue

Eagle Pharmaceuticals: Q4 Earnings Snapshot Hosted

WebDec 31, 2024 · Find out how Eagle Pharmaceuticals, Inc. (EGRX) is performing against its competitors. Compare financial ratios of 10,000 largest U.S. public companies with industry averages. ... 2834 - Pharmaceutical Preparations: Revenue in 2024: $171,546 thousand (ranked #190 out of 638 companies in the industry) Assets as of 12/31/2024 : $253,732 ... WebApr 14, 2024 · The company has a market cap of $5.22 billion, a P/E ratio of 12.51 and a beta of 1.31. Eagle Materials ( NYSE:EXP - Get Rating) last posted its quarterly earnings results on Thursday, January 26th. The construction company reported $3.20 earnings per share for the quarter, topping the consensus estimate of $3.19 by $0.01.

Eagle pharmaceuticals revenue

Did you know?

WebMar 13, 2024 · Eagle Pharmaceuticals , which belongs to the Zacks Medical - Products industry, posted revenues of $60.7 million for the quarter ended December 2024, … WebNov 7, 2024 · Eagle Pharmaceuticals, which belongs to the Zacks Medical - Products industry, posted revenues of $65.9 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate...

WebMar 7, 2024 · Eagle Pharmaceuticals , which belongs to the Zacks Medical - Products industry, posted revenues of $42.32 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 10.57%. WebMar 27, 2024 · Eagle Pharmaceuticals's annual revenues are $10-$50 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Medicinal …

Web19 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Eagle Pharmaceuticals (EGRX) WebScott Tarriff is the founder of Eagle Pharmaceuticals and has served as its Chief Executive Officer and as a member of the Board since its inception in January 2007. Mr. Tarriff has also served as Eagle’s President since September 2024. Prior to founding Eagle, Mr. Tarriff held several key executive-level positions at publicly traded companies.

WebMar 13, 2024 · Full-year 2024 revenue was $316.6 million, compared to $171.5 million in 2024. Net product sales during the fourth quarter of 2024 were $37.2 million, compared to $16.2 million in Q4 of 2024. Full ...

Web14 Medical Sales Jobs jobs available in Ashburn, VA on Indeed.com. Apply to Pharmaceutical Sales Representative, Solutions Engineer, Territory Representative and … can chewable tablets be swallowedWebMar 13, 2024 · Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings and Revenue Estimates Zacks Mar. 13, 2024, 08:05 AM Eagle Pharmaceuticals (EGRX) came out … fish in light bulbWebMay 9, 2024 · Eagle Pharmaceuticals , which belongs to the Zacks Medical - Products industry, posted revenues of $115.87 million for the quarter ended March 2024, missing the Zacks Consensus Estimate by 5.32%. fish in lemon cream sauceWebNov 9, 2024 · Following the latest upgrade, the three analysts covering Eagle Pharmaceuticals provided consensus estimates of US$273m revenue in 2024, which would reflect an uneasy 8.5% decline on its sales ... fish in lemon juiceWebEagle Pharmaceutical Corp Revenue $246.2 M Employees 102 Primary Industries Pharmaceuticals Manufacturing Funding History Eagle Pharmaceuticals raised a total of $200.3 M in funding over 2 rounds, and is a public traded company. CEO Scott Tarriff Stock Symbol NASDAQ: EGRX Eagle Pharmaceuticals Executive Team & Key Decision Makers fish in lemon sauceWebNov 7, 2024 · Eagle Pharmaceuticals , which belongs to the Zacks Medical - Products industry, posted revenues of $65.9 million for the quarter ended September 2024, … fish in lifeguard bellycan chewable vyvanse be cut in half